Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruth Murphy

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
The British Journal of Dermatology|September 23, 2023
British Association of Dermatologists guidelines for biologic therapy for psoriasis 2023: a pragmatic updateCatherine H Smith, Zenas Z N Yiu, Tracy Bale, et al.
Rheumatology (Oxford, England)|October 3, 2025
British Association of Dermatologists and British Society for Rheumatology living guideline for managing people with Behçets 2025Ruth Murphy, Robert J Moots, Paul Brogan, et al.
The British Journal of Dermatology|September 29, 2025
British Association of Dermatologists and British Society for Rheumatology living guideline for managing people with Behçets 2025Ruth Murphy, Robert J Moots, Paul Brogan, et al.
JAMA Dermatology|September 14, 2017
Safety of Systemic Agents for the Treatment of Pediatric PsoriasisInge M G J Bronckers, Marieke M B Seyger, Dennis P West, et al.
JAMA Dermatology|September 19, 2019
Association of Serum Ustekinumab Levels With Clinical Response in PsoriasisTeresa Tsakok, Nina Wilson, Nick Dand, et al.
JAMA Dermatology|February 6, 2020
A Comparison of Psoriasis Severity in Pediatric Patients Treated With Methotrexate vs Biologic AgentsInge M G J Bronckers, Amy S Paller, Dennis P West, et al.
Rheumatology (Oxford, England)|April 3, 2014
Mucocutaneous manifestations in a UK national cohort of juvenile-onset systemic lupus erythematosus patientsDirekrit Chiewchengchol, Ruth Murphy, Thomas Morgan, et al.
Annals of the Rheumatic Diseases|November 1, 2017
Development of a consensus core dataset in juvenile dermatomyositis for clinical use to inform researchLiza J McCann, Clarissa A Pilkington, Adam M Huber, et al.
Clinical and Translational Science|April 30, 2026
Evaluation of a Therapeutic Drug Monitoring Strategy for Adalimumab in Psoriasis: A Prospective Pharmacokinetic-Pharmacodynamic StudyShan Pan, Teresa Tsakok, Ruoheng Wei, et al.
Clinical and Translational Science|January 30, 2020
Using Real-World Data to Guide Ustekinumab Dosing Strategies for Psoriasis: A Prospective Pharmacokinetic-Pharmacodynamic StudyShan Pan, Teresa Tsakok, Nick Dand, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
The British Journal of Dermatology|September 23, 2023
British Association of Dermatologists guidelines for biologic therapy for psoriasis 2023: a pragmatic updateCatherine H Smith, Zenas Z N Yiu, Tracy Bale, et al.
Rheumatology (Oxford, England)|October 3, 2025
British Association of Dermatologists and British Society for Rheumatology living guideline for managing people with Behçets 2025Ruth Murphy, Robert J Moots, Paul Brogan, et al.
The British Journal of Dermatology|September 29, 2025
British Association of Dermatologists and British Society for Rheumatology living guideline for managing people with Behçets 2025Ruth Murphy, Robert J Moots, Paul Brogan, et al.
JAMA Dermatology|September 14, 2017
Safety of Systemic Agents for the Treatment of Pediatric PsoriasisInge M G J Bronckers, Marieke M B Seyger, Dennis P West, et al.
JAMA Dermatology|September 19, 2019
Association of Serum Ustekinumab Levels With Clinical Response in PsoriasisTeresa Tsakok, Nina Wilson, Nick Dand, et al.
JAMA Dermatology|February 6, 2020
A Comparison of Psoriasis Severity in Pediatric Patients Treated With Methotrexate vs Biologic AgentsInge M G J Bronckers, Amy S Paller, Dennis P West, et al.
Rheumatology (Oxford, England)|April 3, 2014
Mucocutaneous manifestations in a UK national cohort of juvenile-onset systemic lupus erythematosus patientsDirekrit Chiewchengchol, Ruth Murphy, Thomas Morgan, et al.
Annals of the Rheumatic Diseases|November 1, 2017
Development of a consensus core dataset in juvenile dermatomyositis for clinical use to inform researchLiza J McCann, Clarissa A Pilkington, Adam M Huber, et al.
Clinical and Translational Science|April 30, 2026
Evaluation of a Therapeutic Drug Monitoring Strategy for Adalimumab in Psoriasis: A Prospective Pharmacokinetic-Pharmacodynamic StudyShan Pan, Teresa Tsakok, Ruoheng Wei, et al.
Clinical and Translational Science|January 30, 2020
Using Real-World Data to Guide Ustekinumab Dosing Strategies for Psoriasis: A Prospective Pharmacokinetic-Pharmacodynamic StudyShan Pan, Teresa Tsakok, Nick Dand, et al.
Pageof 7